ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

A randomised controlled trial of single-dose oral Ivermectin in patients with COVID-19 infection

Implementing Organization

All India Institute of Medical Sciences
Principal Investigator
Dr Anant Mohan
Professor
|
All India Institute of Medical Sciences

About

This project aims to evaluate the efficacy of (1) single-dose Ivermectin in reducing viral load in COVID-19 patients, (2) Ivermectin in time with clinical improvement, the percentage of patients progressing to severe disease, and frequency of adverse events in both arms.

Patents

NA

Achievements

NA

Outcome / Output

A single oral administration of Ivermectin at two dosage strength (24 mg and 12 mg) to patients with mild and moderate COVID-19 in reducing SARS-COV-2 viral load was tested. There was no difference in the decline of viral load on day five between the three arms. No serious adverse events were encountered in patients with mild and moderate COVID-19.

Publications

NA

Related Research

View All
Funding Organization
Funding Organization
Department of Science and Technology (DST)
Quick Information
Focus Area
COVID-19 Therapeutics
Start Year
2020
End Year
2020
Sanction Amount
₹ NA
Status
Completed
Contact
anantmohan@yahoo.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
NA
No. of Patents
Filed : 00
Grant : 00
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…
Recently added across the portal